Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition.

Stove C, Vanrobaeys F, Devreese B, Van Beeumen J, Mareel M, Bracke M.

Oncogene. 2004 Jul 8;23(31):5330-9.

PMID:
15064726
2.

Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.

Fumagalli M, Musso T, Vermi W, Scutera S, Daniele R, Alotto D, Cambieri I, Ostorero A, Gentili F, Caposio P, Zucca M, Sozzani S, Stella M, Castagnoli C.

Exp Dermatol. 2007 Jul;16(7):600-10.

PMID:
17576240
3.

Expression of FLRG, a novel activin A ligand, is regulated by TGF-beta and during hematopoiesis [corrected].

Maguer-Satta V, Bartholin L, Jeanpierre S, Gadoux M, Bertrand S, Martel S, Magaud JP, Rimokh R.

Exp Hematol. 2001 Mar;29(3):301-8. Erratum in: Exp Hematol 2001 Jul;29(7):922.

PMID:
11274757
4.

Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.

Lux A, Beil C, Majety M, Barron S, Gallione CJ, Kuhn HM, Berg JN, Kioschis P, Marchuk DA, Hafner M.

J Biol Chem. 2005 Mar 4;280(9):8482-93. Epub 2004 Dec 16.

5.

Transforming growth factor beta1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation.

Fazzini M, Vallejo G, Colman-Lerner A, Trigo R, Campo S, Barañao JL, Saragüeta PE.

J Cell Physiol. 2006 Apr;207(1):40-8.

PMID:
16245315
7.

Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function.

Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, Magaud JP, Rimokh R.

Oncogene. 2002 Mar 28;21(14):2227-35.

8.

Upregulation of activin signaling in experimental colitis.

Zhang YQ, Resta S, Jung B, Barrett KE, Sarvetnick N.

Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G768-80. doi: 10.1152/ajpgi.90631.2008. Epub 2009 Jul 30.

9.

The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS.

Dev Cell. 2005 Oct;9(4):535-43.

10.

Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.

Krneta J, Kroll J, Alves F, Prahst C, Sananbenesi F, Dullin C, Kimmina S, Phillips DJ, Augustin HG.

Cancer Res. 2006 Jun 1;66(11):5686-95.

11.

Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth.

Razanajaona D, Joguet S, Ay AS, Treilleux I, Goddard-Léon S, Bartholin L, Rimokh R.

Cancer Res. 2007 Aug 1;67(15):7223-9.

12.

Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion.

Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Thompson JG, Armstrong DT, Gilchrist RB.

Biol Reprod. 2007 May;76(5):848-57. Epub 2006 Dec 27.

PMID:
17192514
13.

Expression and regulation of phospholipase D isoenzymes in human melanoma cells and primary melanocytes.

Riebeling C, Müller C, Geilen CC.

Melanoma Res. 2003 Dec;13(6):555-62.

PMID:
14646617
14.

Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis.

Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Ying SY.

Exp Biol Med (Maywood). 2006 May;231(5):534-44. Review. Erratum in: Exp Biol Med (Maywood). 2006 Sep;231(8):1448. Chung, Jody [corrected to Chuang, Jody].

PMID:
16636301
15.

Isolation and characterization of Xenopus follistatin and activins.

Fukui A, Nakamura T, Sugino K, Takio K, Uchiyama H, Asashima M, Sugino H.

Dev Biol. 1993 Sep;159(1):131-9.

PMID:
8365557
16.

Follistatin is a developmentally regulated cytokine in neural differentiation.

Hashimoto M, Nakamura T, Inoue S, Kondo T, Yamada R, Eto Y, Sugino H, Muramatsu M.

J Biol Chem. 1992 Apr 15;267(11):7203-6.

17.

Activin A in JEG-3 cells: potential role as an autocrine regulator of steroidogenesis in humans.

Ni X, Luo S, Minegishi T, Peng C.

Biol Reprod. 2000 May;62(5):1224-30.

PMID:
10775170
18.

Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis.

Patella S, Phillips DJ, Tchongue J, de Kretser DM, Sievert W.

Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G137-44. Epub 2005 Aug 25.

19.

Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding.

Fischer WH, Park M, Donaldson C, Wiater E, Vaughan J, Bilezikjian LM, Vale W.

J Endocrinol. 2003 Jan;176(1):61-8.

20.

An activin-A/C chimera exhibits activin and myostatin antagonistic properties.

Muenster U, Harrison CA, Donaldson C, Vale W, Fischer WH.

J Biol Chem. 2005 Nov 4;280(44):36626-32. Epub 2005 Aug 29.

Supplemental Content

Support Center